N/A
N=44
Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary Defect
Multiple Sclerosis · Glaucoma
Bottom Line
View on ClinicalTrials.gov: NCT02772666 ↗Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Nov 2016
Primary outcome: Primary: Number of Participants With Detected Relative Afferent Pupillary Defect (RAPD) — 44; 37 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- O-Glass (Device); Swinging Flashlight Test (Other)
- Age
- Adult · 20+ yrs
- Sex
- All
- Sponsor
- Mashhad University of Medical Sciences
- Primary completion
- May 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Detected Relative Afferent Pupillary Defect (RAPD) |
44; 37 | — |
Summary
This study is to evaluate the ability of a newly designed device, Optic Nerve Glass (O-Glass) to detect relative afferent pupillary defect (RAPD). In this prospective study, 44 patients (diagnosed RAPD- positive) enrolled the study. They were examined for an RAPD by O-Glass and also manual swinging flashlight method (SFM) . This newly designed instrument captures and records eye pictures. The images will be processed and analyzed using computerized software to calculate pupillary measurements.
Eligibility Criteria
Inclusion Criteria
- positive relative afferent pupillary defect
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT02772666). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.